A Prospective Comparative Study Between Oncoplastic Breast Surgery and Standard Wide Local Excision

A Prospective Comparative Study Between Oncoplastic Breast Surgery and Standard Wide Local Excision:Margin Length and Patient Satisfaction

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02923635

Enrollment

Registered

2016-10-04

Start date

2012-09-30

Completion date

2016-06-30

Last updated

2016-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Oncoplastic breast surgery, Standard Wide Local Excision

Brief summary

The aim of this study is to asses the oncological safety of oncoplastic breast surgery, and its impact on patient satisfaction.

Detailed description

This non-randomized prospective trial was conducted on70 female patients presented to tertiary breast unit-Ain Shams University hospitals with breast cancer during the period from September 2012 to February 2013. All patients sharing in the study signed an informed consent that was approved in the ethical committee held on April 2012. Patients were classified in two groups each one 35 patients: group (A) standard wide local excision and group (B) oncoplastic group. Standard wide local excision done by general breast surgeons while oncoplastic surgeries done by breast surgeon assisted by plastic surgeon. The following data were recorded: Age, family history, margin length, weight and volume of the specimen, margin status and patient satisfaction.

Interventions

PROCEDUREStandard wide local excision.

Excision of breast cancer without integration of plastic technique

PROCEDUREoncoplastic breast surgery.

Integration of plastic techniques with oncological surgery for resection of breast cancer.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

No minimum to 60 Years

Healthy volunteers

Inclusion criteria

* Patients with macromastia in oncoplastic group. * Tumors \>20% of breast volume in oncoplastic group. * Young patients in oncoplastic group * Tumors in medial or central quadrants in oncoplastic group

Exclusion criteria

* Patients \>60 years. * Patients with co-morbidities in oncoplastic group. * Tumors \>20% of breast volume in standard group. * Tumors in medial or central quadrants in standard group

Design outcomes

Primary

Measure	Time frame
Margins in all specimens measured in millimeters	Two years

Secondary

Measure	Time frame
Patient satisfaction assessed using questionnaire	two years

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026